Raffit Hassan, PhD

Head, Thoracic and Solid Tumor Immunotherapy Section at National Cancer Institute

Speaker

Dr. Raffit Hassan is a Senior Investigator and Chief of the Thoracic and GI Malignancies Branch at the National Cancer Institute, NIH. He has played a pivotal role in validating the tumor differentiation antigen mesothelin as a target for cancer therapy and development of mesothelin targeted immunotherapy. His current research focus is on developing mesothelin directed adoptive cellular therapies including clinical trials of T cell receptor fusion constructs, gavo-cel and TC-510. Additionally, his lab has developed highly effective anti-mesothelin hYP218 CAR T cells that will soon enter the clinic.